» Articles » PMID: 31730329

Activatable Phototheranostic Materials for Imaging-Guided Cancer Therapy

Overview
Date 2019 Nov 16
PMID 31730329
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer theranostics, which combines diagnostic and therapeutic effects into one entity, holds promise in precision medicine. Conventional theranostic agents possess always-on imaging signals and cytotoxic effects and thus often encounter poor selectivity or specificity in cancer treatment. To tackle this issue, activatable phototheranostic materials (PMs) have been developed to simultaneously and specifically turn on their diagnostic signals (fluorescence/self-luminescence/photoacoustic signals) and photothermal/photodynamic effects in response to cancer hallmarks. This Review summarizes the recent progress in the design, synthesis and proof-of-concept applications of activatable PMs. The molecular engineering strategy to increase tumor accumulation and enhance treatment efficacy are highlighted. Current challenges and future perspectives in this emerging field are also discussed.

Citing Articles

Design and synthesis of a novel chiral photoacoustic probe and accurate imaging detection of hydrogen peroxide in vivo.

Wang S, Huang W, Lin Q, Feng Y, Wei Q, Xu J Anal Bioanal Chem. 2024; 416(23):5205-5214.

PMID: 39078455 DOI: 10.1007/s00216-024-05463-x.


Photothermal Temperature-Modulated Cancer Metastasis Harnessed Using Proteinase-Triggered Assembly of Near-Infrared II Photoacoustic/Photothermal Nanotheranostics.

Chuang Y, Hsia Y, Chu C, Maharajan S, Hsu F, Lee H ACS Appl Mater Interfaces. 2024; 16(31):40611-40627.

PMID: 39046148 PMC: 11310908. DOI: 10.1021/acsami.4c07173.


Biomedical applications of stimuli-responsive nanomaterials.

Chen X, Wu D, Chen Z MedComm (2020). 2024; 5(8):e643.

PMID: 39036340 PMC: 11260173. DOI: 10.1002/mco2.643.


A highly fluorescent and readily accessible all-organic photosensitizer model for advancing image-guided cancer PDT.

Garcia-Sampedro A, Prieto-Castaneda A, Agarrabeitia A, Banuelos J, Garcia-Moreno I, Villanueva A J Mater Chem B. 2024; 12(31):7618-7625.

PMID: 38994651 PMC: 11305095. DOI: 10.1039/d4tb00385c.


Totally Caged Type I Pro-Photosensitizer for Oxygen-Independent Synergistic Phototherapy of Hypoxic Tumors.

Zeng Q, Li X, Li J, Shi M, Yao Y, Guo L Adv Sci (Weinh). 2024; 11(31):e2400462.

PMID: 38885361 PMC: 11336908. DOI: 10.1002/advs.202400462.